Effects of non-ablative vaginal Er:YAG laser on female mild-to-moderate stress urinary incontinence
10.3969/j.issn.1009-8291.2025.07.006
- VernacularTitle:非剥脱阴道Er:YAG激光对轻中度女性压力性尿失禁患者的疗效
- Author:
Xin WANG
1
;
Zhipeng ZHANG
;
Lingfeng MENG
;
Shengfei XU
;
Jiqiong ZHENG
;
Hui WANG
;
Xiaoyi YUAN
;
Zhengwang ZHANG
;
Jianwei LYU
;
Yaoguang ZHANG
Author Information
1. 北京医院泌尿外科,国家老年医学中心,中国医学科学院老年医学研究院,北京 100730
- Publication Type:Journal Article
- Keywords:
stress urinary incontinence;
erbium-doped yttrium aluminum garnet laser(Er:YAG);
quality of life;
International Consultation on Incontinence Questionnaire-Short Form;
women
- From:
Journal of Modern Urology
2025;30(7):582-586,592
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy of non-ablative vaginal erbium-doped yttrium aluminum garnet(Er:YAG)laser therapy in improving symptoms in women with mild-to-moderate stress urinary incontinence(SUI).Methods A prospective,multicenter,randomized controlled trial was conducted.A total of 126 female SUI patients were enrolled and randomized in a 2∶1 ratio to the treatment group(n=84,receiving Er:YAG laser therapy)and the sham control group(n=42,undergoing non-energized laser device with shielded beam).Efficacy outcomes were compared between the two groups,including the International Consultation on Incontinence Questionnaire-Short Form(ICI-Q-SF)scores at baseline and 1,3,6 months after treatment,response rate 3 month after treatment,urine leakage volume,daily incontinence episodes and visual analog scale(VAS).Results One month and 3 months after treatment,the ICI-Q-SF scores in the treatment group(8.07±3.33 and 7.04±3.04,respectively)were significantly lower than those in the control group(9.57±4.03 and 9.65±3.27,respectively;both P＜0.05).The 3-month response rate was significantly higher in the treatment group(71.43％)compared to the control group(35.71％,P＜0.05).Improvements in urine leakage volume 1 and 3 months after treatment were significantly greater in the treatment group versus the control group(both P＜0.05).A statistically significant reduction in daily incontinence episodes was observed in the treatment group 1 month after treatment compared to the control group[2(0,5)times vs.4(2,8)times,P＜0.05].VAS score in the treatment group markedly decreased 1 month after treatment,comparable to the level observed in the control group[0(0,2.45)vs.0(0,0),P＜0.05].Conclusion Non-ablative vaginal Er:YAG laser therapy significantly alleviates symptoms in women with mild-to-moderate SUI and represents a viable treatment option for this condition.
